These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8877878)

  • 1. Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407.
    Bhardwaj R; Blanchard J
    J Pharm Sci; 1996 Sep; 85(9):915-9. PubMed ID: 8877878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Feb; 87(2):226-30. PubMed ID: 9519158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur.
    Zhang L; Parsons DL; Navarre C; Kompella UB
    J Control Release; 2002 Dec; 85(1-3):73-81. PubMed ID: 12480313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of additives on a thermosensitive hydrogel for buccal delivery of salbutamol: relation between micellization, gelation, mechanic and release properties.
    Zeng N; Dumortier G; Maury M; Mignet N; Boudy V
    Int J Pharm; 2014 Jun; 467(1-2):70-83. PubMed ID: 24699353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-I.
    Bhardwaj R; Hadley ME; Dorr RT; Dvorakova K; Brooks C; Blanchard J
    Pharm Res; 2000 May; 17(5):593-9. PubMed ID: 10888312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
    Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP
    Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
    Radivojša M; Grabnar I; Ahlin Grabnar P
    Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
    Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
    Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of an in situ forming gel system for sustained delivery of Florfenicol.
    Yu ZG; Geng ZX; Liu TF; Jiang F
    J Vet Pharmacol Ther; 2015 Jun; 38(3):271-7. PubMed ID: 25287575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration.
    Arbelaez-Camargo D; Suñé-Negre JM; Roig-Carreras M; García-Montoya E; Pérez-Lozano P; Miñarro-Carmona M; Ticó-Grau JR
    Int J Pharm; 2016 Feb; 498(1-2):142-52. PubMed ID: 26685726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
    Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
    Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Oct; 87(10):1190-5. PubMed ID: 9758675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties.
    Bruschi ML; Jones DS; Panzeri H; Gremião MP; de Freitas O; Lara EH
    J Pharm Sci; 2007 Aug; 96(8):2074-89. PubMed ID: 17301966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of nanostructured environmentally responsive system containing hydroxypropyl methylcellulose for nose-to-brain administration of meloxicam.
    Botan MVG; da Silva JB; Bruschi ML
    Int J Biol Macromol; 2024 Mar; 262(Pt 1):130015. PubMed ID: 38331066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hemelryck SV; Dewulf J; Niekus H; van Heerden M; Ingelse B; Holm R; Mannaert E; Langguth P
    Int J Pharm X; 2019 Dec; 1():100016. PubMed ID: 31517281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
    Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
    Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
    Sherif S; Bendas ER; Badawy S
    Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.